BCL2 and Anaplastic (Malignant) Meningioma: Furthermore, we demonstrated that gemcitabine enhanced the effects of radiation together with navitoclax, an inhibitor of anti-apoptotic BCL-2 family proteins [10], suggesting a role for gemcitabine as an enhancer of treatments for malignant meningioma.